Hoth Historical Financial Ratios
| HOTH Stock | USD 1.17 0.02 1.68% |
Hoth Therapeutics is recently reporting on over 91 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.53 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Hoth Therapeutics financial condition quickly.
Hoth |
About Hoth Financial Ratios Analysis
Hoth TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Hoth Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Hoth financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Hoth Therapeutics history.
Hoth Therapeutics Financial Ratios Chart
Hoth Therapeutics financial ratios usually calculated using numerical values taken directly from Hoth Therapeutics financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Hoth Therapeutics. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
As of now, Hoth Therapeutics' EV To Operating Cash Flow is increasing as compared to previous years. The Hoth Therapeutics' current EV To Free Cash Flow is estimated to increase to 0.54, while PTB Ratio is projected to decrease to 0.53. Add Fundamental
Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Hoth Therapeutics. There are two different methods for calculating Hoth Therapeutics invested capital: operating approach and financing approach. Understanding Hoth Therapeutics invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Hoth Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.As of now, Hoth Therapeutics' EV To Operating Cash Flow is increasing as compared to previous years. The Hoth Therapeutics' current EV To Free Cash Flow is estimated to increase to 0.54, while PTB Ratio is projected to decrease to 0.53.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 12.19 | 4.85 | 13.89 | 12.34 | Net Debt To EBITDA | 0.61 | 0.6 | 1.2 | 1.26 |
Hoth Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Hoth Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hoth Therapeutics fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 23.68 | 6.31 | 1.49 | 1.82 | 0.56 | 0.53 | |
| Book Value Per Share | 6.54 | 9.39 | 11.06 | 4.28 | 2.59 | 4.57 | |
| Free Cash Flow Yield | (0.0889) | (0.22) | (0.83) | (1.0) | (1.72) | (1.63) | |
| Operating Cash Flow Per Share | (13.5) | (12.4) | (13.54) | (7.76) | (2.48) | (2.6) | |
| Pb Ratio | 23.68 | 6.31 | 1.49 | 1.82 | 0.56 | 0.53 | |
| Free Cash Flow Per Share | (13.75) | (12.74) | (13.67) | (7.83) | (2.48) | (2.6) | |
| Roic | (3.22) | (1.57) | (1.43) | (2.22) | (0.87) | (0.91) | |
| Net Income Per Share | (20.99) | (14.56) | (16.03) | (9.75) | (2.3) | (2.42) | |
| Cash Per Share | 6.8 | 9.49 | 11.68 | 5.54 | 2.73 | 4.94 | |
| Pocfratio | (11.47) | (4.78) | (1.22) | (1.0) | (0.58) | (0.61) | |
| Pfcf Ratio | (11.25) | (4.65) | (1.21) | (1.0) | (0.58) | (0.61) | |
| Days Payables Outstanding | 4.7K | 1.8K | 2.81 | 3.8K | 4.4K | 2.7K | |
| Roe | (3.21) | (1.55) | (1.45) | (2.28) | (0.89) | (0.93) | |
| Ev To Operating Cash Flow | (11.13) | (4.35) | (0.51) | (0.31) | 0.51 | 0.54 | |
| Pe Ratio | (7.37) | (4.07) | (1.03) | (0.8) | (0.63) | (0.66) | |
| Return On Tangible Assets | (2.71) | (1.37) | (1.3) | (1.73) | (0.82) | (0.87) | |
| Ev To Free Cash Flow | (10.92) | (4.23) | (0.51) | (0.31) | 0.51 | 0.54 | |
| Earnings Yield | (0.14) | (0.25) | (0.97) | (1.25) | (1.6) | (1.52) | |
| Net Debt To E B I T D A | 0.22 | 0.36 | 0.61 | 0.6 | 1.2 | 1.26 | |
| Current Ratio | 5.99 | 15.32 | 12.19 | 4.85 | 13.89 | 12.34 | |
| Tangible Book Value Per Share | 6.54 | 9.39 | 11.06 | 4.28 | 2.59 | 4.57 | |
| Graham Number | 55.56 | 55.47 | 63.16 | 30.63 | 11.57 | 10.99 | |
| Shareholders Equity Per Share | 6.54 | 9.39 | 11.06 | 4.28 | 2.59 | 4.57 | |
| Graham Net Net | 5.6 | 8.28 | (42.07) | 4.18 | 2.52 | 2.64 | |
| Enterprise Value Over E B I T D A | (7.13) | (3.65) | (0.44) | (0.27) | 0.56 | 0.59 | |
| Price Earnings Ratio | (7.37) | (4.07) | (1.03) | (0.8) | (0.63) | (0.66) | |
| Price Book Value Ratio | 23.68 | 6.31 | 1.49 | 1.82 | 0.56 | 0.53 | |
| Days Of Payables Outstanding | 4.7K | 1.8K | 2.81 | 3.8K | 4.4K | 2.7K | |
| Price To Operating Cash Flows Ratio | (11.47) | (4.78) | (1.22) | (1.0) | (0.58) | (0.61) | |
| Price To Free Cash Flows Ratio | (11.25) | (4.65) | (1.21) | (1.0) | (0.58) | (0.61) | |
| Company Equity Multiplier | 1.18 | 1.13 | 1.11 | 1.32 | 1.08 | 1.6 | |
| Return On Capital Employed | (3.22) | (1.48) | (1.39) | (2.06) | (0.87) | (0.91) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Return On Assets (0.59) | Return On Equity (1.13) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.